abstract |
Novel compounds of formula (I), wherein R<1>, R<2>, R<2'>, R<2''>, R<3>, R<4>, R<5>, R<5'>, R<5''>, R<5'''>, R<5''''>, X, Y, U, V and W have the meanings given in claim no.1, are inhibitors of the coagulation factors Xa and VIIa and can be used for treating thromboses, myocardial infarct, arteriosclerosis, infections, apoplexia, angina pectoris, restenosis following angioplasty, intermittent claudication, tumors, tumor diseases and/or tumor metastases. |